Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:20:01 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



Q:AEMD - AETHLON MEDICAL INC - http://www.aethlonmedical.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AEMD - Q0.21.01·1.500.11.39+0.0352.65.76541.33  1.40  1.335.00  1.303516:00:01Feb 2115 min RT 2¢

Recent Trades - Last 10 of 54
Time ETExPriceChangeVolume
16:00:01Q1.380.0151
16:00:00Q1.380.01561
15:59:13Q1.380.01553
15:59:13Q1.380.01511
15:49:30Q1.38190.01692
15:35:30Q1.390.035139
15:12:47Q1.38180.01681
15:07:24Q1.39890.03391
15:07:24Q1.39890.03391
14:36:12Q1.3960.041600

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-02-21 08:01U:AEMDNews ReleaseAethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
2024-02-14 16:15U:AEMDNews ReleaseAethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
2024-02-07 08:00U:AEMDNews ReleaseAethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
2023-11-14 16:15U:AEMDNews ReleaseAethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
2023-11-13 08:01U:AEMDNews ReleaseAethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
2023-11-06 08:01U:AEMDNews ReleaseAethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
2023-10-10 08:01U:AEMDNews ReleaseAethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier ‚ ® in Oncology
2023-10-04 08:01U:AEMDNews ReleaseAethlon Announces Reverse Stock Split
2023-08-30 08:01U:AEMDNews ReleaseAethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-10 16:15U:AEMDNews ReleaseAethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
2023-08-03 08:01U:AEMDNews ReleaseAethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
2023-07-24 08:01U:AEMDNews ReleaseAethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier ‚ ® to Expand the Utility of Unused, Donated Kidneys for Transplant
2023-07-06 14:17U:AEMDNews ReleaseAethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
2023-06-28 16:15U:AEMDNews ReleaseAethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
2023-06-22 08:01U:AEMDNews ReleaseAethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
2023-06-21 08:01U:AEMDNews ReleaseAethlon Medical Announces Investigation of the Hemopurifier ‚ ® for Use in Organ Transplantation
2023-06-14 08:01U:AEMDNews ReleaseAethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
2023-06-01 15:51U:AEMDNews ReleaseAethlon Medical to Present at the 13th Annual LD Micro Invitational
2023-05-22 08:01U:AEMDNews ReleaseAethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier ‚ ® to Treat Severe COVID-19 in India